Somaxon Pharmaceuticals Acquired For $25M
socalTECH
DECEMBER 11, 2012
According to the two companies, Pernix will acquire Somaxon in a stock-for-stock transaction worth a total of $25M in total equity. Somaxon had 12 months net sales of approximately $11.7M The company has been looking for a buyer since December of 2011, when it drastically cut its staff and said it had hired an investment banker.
Let's personalize your content